246 related articles for article (PubMed ID: 30871913)
1. Drug repositioning in head and neck squamous cell carcinoma: An integrated pathway analysis based on connectivity map and differential gene expression.
Wei GG; Gao L; Tang ZY; Lin P; Liang LB; Zeng JJ; Chen G; Zhang LC
Pathol Res Pract; 2019 Jun; 215(6):152378. PubMed ID: 30871913
[TBL] [Abstract][Full Text] [Related]
2. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.
Shen Y; Liu J; Zhang L; Dong S; Zhang J; Liu Y; Zhou H; Dong W
Biomed Res Int; 2019; 2019():7376034. PubMed ID: 31485443
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of key genes and signal pathways of human papilloma virus-related head and neck squamous cell carcinoma].
Wang KP; Yuan YJ; Zhu JQ; Li BL; Zhang TT
Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Aug; 55(8):571-577. PubMed ID: 32842349
[No Abstract] [Full Text] [Related]
4. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database.
Luo B; Gu YY; Wang XD; Chen G; Peng ZG
Pathol Res Pract; 2018 Nov; 214(11):1854-1867. PubMed ID: 30244948
[TBL] [Abstract][Full Text] [Related]
5. Novel drug candidate for the treatment of several soft‑tissue sarcoma histologic subtypes: A computational method using survival‑associated gene signatures for drug repurposing.
Yang X; Huang WT; Wu HY; He RQ; Ma J; Liu AG; Chen G
Oncol Rep; 2019 Apr; 41(4):2241-2253. PubMed ID: 30816547
[TBL] [Abstract][Full Text] [Related]
6. Identification of potential core genes and pathways predicting pathogenesis in head and neck squamous cell carcinoma.
Wang M; Zhong B; Li M; Wang Y; Yang H; Du K
Biosci Rep; 2021 May; 41(5):. PubMed ID: 33982750
[TBL] [Abstract][Full Text] [Related]
7. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
Jin Y; Yang Y
Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
[TBL] [Abstract][Full Text] [Related]
8. Novel drug candidates for treating esophageal carcinoma: A study on differentially expressed genes, using connectivity mapping and molecular docking.
Chen YT; Xie JY; Sun Q; Mo WJ
Int J Oncol; 2019 Jan; 54(1):152-166. PubMed ID: 30387840
[TBL] [Abstract][Full Text] [Related]
9. The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasets.
Pang JS; Li ZK; Lin P; Wang XD; Chen G; Yan HB; Li SH
Oncol Rep; 2019 Apr; 41(4):2089-2102. PubMed ID: 30816528
[TBL] [Abstract][Full Text] [Related]
10. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.
Yang K; Zhang S; Zhang D; Tao Q; Zhang T; Liu G; Liu X; Zhao T
Int J Clin Oncol; 2019 Sep; 24(9):1030-1041. PubMed ID: 30937621
[TBL] [Abstract][Full Text] [Related]
11. Expression profile analysis of head and neck squamous cell carcinomas using data from The Cancer Genome Atlas.
Yan L; Zhan C; Wu J; Wang S
Mol Med Rep; 2016 May; 13(5):4259-65. PubMed ID: 27035117
[TBL] [Abstract][Full Text] [Related]
12. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
13. Critical genes in head and neck squamous cell carcinoma revealed by bioinformatic analysis of gene expression data.
Wang B; Wang T; Cao XL; Li Y
Genet Mol Res; 2015 Dec; 14(4):17406-15. PubMed ID: 26782382
[TBL] [Abstract][Full Text] [Related]
14. Identification of putative drugs for gastric adenocarcinoma utilizing differentially expressed genes and connectivity map.
Chen ZX; Zou XP; Yan HQ; Zhang R; Pang JS; Qin XG; He RQ; Ma J; Feng ZB; Chen G; Gan TQ
Mol Med Rep; 2019 Feb; 19(2):1004-1015. PubMed ID: 30569111
[TBL] [Abstract][Full Text] [Related]
15. Integrin α-5 as a potential biomarker of head and neck squamous cell carcinoma.
Zou B; Wang D; Xu K; Yuan DY; Meng Z; Zhang B
Oncol Lett; 2019 Oct; 18(4):4048-4055. PubMed ID: 31579416
[TBL] [Abstract][Full Text] [Related]
16. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
Namani A; Matiur Rahaman M; Chen M; Tang X
BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive bioinformatics analysis and experimental validation: An anoikis-related gene prognostic model for targeted drug development in head and neck squamous cell carcinoma.
Qiu L; Tao A; Sun X; Liu F; Ge X; Li C
Oncol Res; 2023; 31(5):715-752. PubMed ID: 37547764
[TBL] [Abstract][Full Text] [Related]
18. Robust rank aggregation and cibersort algorithm applied to the identification of key genes in head and neck squamous cell cancer.
Chen T; Hua W; Xu B; Chen H; Xie M; Sun X; Ge X
Math Biosci Eng; 2021 May; 18(4):4491-4507. PubMed ID: 34198450
[TBL] [Abstract][Full Text] [Related]
19. Using Prognosis-Related Gene Expression Signature and Connectivity Map for Personalized Drug Repositioning in Multiple Myeloma.
Zhu FX; He YC; Zhang JY; Wang HF; Zhong C; Wang XT
Med Sci Monit; 2019 May; 25():3247-3255. PubMed ID: 31048671
[TBL] [Abstract][Full Text] [Related]
20. Identification of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis.
Zhang H; Liu J; Fu X; Yang A
Med Sci Monit; 2017 Dec; 23():5924-5932. PubMed ID: 29240723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
